Cero Therapeutics Holdings, Inc.
PBAX
Revenue
0.00
0.000.00%
-Assets
7.37M
▼-1.68M▼-18.58%
3 Months ChangeLiabilities
9.85M
▼-3.18M▼-24.40%
3 Months ChangeFree Cash Flow
0.00
0.000.00%
-Revenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-05-17
Form 10-Q
ID: 0001213900-24-044805
2024-05-03
Form 8-K
ID: 0001213900-24-039644
2024-05-01
Form 8-K
ID: 0001213900-24-038497
2024-02-28
Form 8-K
ID: 0001213900-24-017770
2024-02-15
Form 8-K
ID: 0001213900-24-014197
2024-02-14
Form 8-K
ID: 0001213900-24-013804
2024-02-12
Form 8-K
ID: 0001213900-24-012571
2024-02-06
Form 8-K
ID: 0001213900-24-010227
2024-01-05
Form 8-K
ID: 0001213900-24-001511
2023-12-11
Form 8-K
ID: 0001213900-23-094779